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Take Home MessageThe goal of invasive mechanical ventilation during ECLS for ARDS should be to decrease the 
intensity of ventilation with the aim of reducing VILI and maximizing the potential benefit of 
ECLS. The EOLIA ventilator protocol during ECLS provides a default minimum standard for 
such ventilation. Future studies should focus on more precisely delineating the best strategies for 
optimizing invasive mechanical ventilation during ECLS for ARDS.
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Abstract
Ventilator-induced lung injury remains a key contributor to the morbidity and mortality of the 
acute respiratory distress syndrome. Efforts to minimize this injury are typically limited by the 
need to preserve adequate gas exchange. In the most severe forms of the syndrome, 
extracorporeal life support is increasingly being deployed for severe hypoxemia or hypercapnic 
acidosis refractory to conventional ventilator management strategies. Data from a recent 
randomized controlled trial, a post-hoc analysis of that trial, a meta-analysis, and a large, 
international, multicenter observational study, all suggest that extracorporeal life support, when 
combined with lower tidal volumes and airway pressures than the current standard of care, may 
improve outcomes compared with conventional management in patients with the most severe 
forms of the acute respiratory distress syndrome. These findings raise important questions not 
only about the optimal ventilator strategies for patients receiving extracorporeal support, but how 
various mechanisms of lung injury in the acute respiratory distress syndrome may potentially be 
mitigated by ultra-lung-protective ventilation strategies when gas exchange is sufficiently 
managed with the extracorporeal circuit. Additional studies are needed to more precisely 
delineate the best strategies for optimizing invasive mechanical ventilation in this patient 
population.
Total word count for abstract: 192
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Key points
 Ventilator-induced lung injury is a major contributor to morbidity and mortality 
in ARDS, driven in large part by injurious mechanical forces
 ECLS can supplement or supplant native lung gas exchange in ARDS, allowing 
for reductions in the mechanical forces contributing to ventilator-induced lung 
injury
 Conventional management strategies (standard of care lung-protective ventilation, 
prone positioning, PEEP titration, conservative fluid balance, and perhaps 
neuromuscular blockade) should be optimized prior to consideration of ECLS
 The ventilation strategies employed in the EOLIA trial are a reasonable default 
standard of care for invasive mechanical ventilation in patients with ARDS 
receiving ECMO, although we suggest targeting respiratory rates of 10 (the lower 
range in EOLIA) or less
 Excess work of breathing may promote lung injury in ARDS and should be 
avoided, whether or not ECLS is used
 More data are needed to determine the ventilator parameters that are associated 
with improved short- and long-term outcomes 
Page 7 of 55  AJRCCM Articles in Press. Published on 14-November-2019 as 10.1164/rccm.201907-1283CI 
 Copyright © 2019 by the American Thoracic Society 
Introduction
Extracorporeal life support (ECLS) can support gas exchange in patients with the acute 
respiratory distress syndrome (ARDS) whose oxygenation or ventilation cannot be maintained 
adequately with best practice conventional mechanical ventilation and adjunctive therapies, 
including prone positioning (1). ECLS enables the use of lower tidal volumes and airway 
pressures in patients whose gas exchange could otherwise be maintained only at the expense of 
injurious mechanical ventilation strategies (1-3). Ventilator-induced lung injury (VILI) is a key 
contributor to morbidity and mortality in ARDS (4) particularly among those considered for 
ECLS. Therefore adopting lung-protective ventilator strategies beyond the current standard of 
care concomitantly with the application of ECLS in these patients, appears to be key to realizing 
the potential benefit of this strategy. The objectives of this review are to summarize the current 
understanding of the role ECLS may play in minimizing VILI; suggest best practice mechanical 
ventilation strategies during ECLS given the existing data; describe the interplay between ECLS, 
gas exchange, and ventilator parameters; and, lastly, identify the areas of research that are 
needed to better inform the optimal management of mechanical ventilation and spontaneous 
breathing efforts during ECLS. The suggestions put forth in this narrative review reflect 
consensus expert opinions of clinicians and researchers with expertise in mechanical ventilation, 
ARDS, and ECLS that originated from a roundtable discussion at the 4th Annual International 
ECMO Network Scientific Meeting in Rome, Italy in 2018 
(https://www.internationalecmonetwork.org/conferences).
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Conventional approaches to minimizing VILI
The main focus of mechanical ventilation in ARDS is to provide adequate gas exchange while 
limiting injury to the organs (4), the contributors to which include barotrauma, volutrauma, 
atelectrauma, ergotrauma, myotrauma, and biotrauma (Figure 1) (5-9). Lung injury may be 
further exacerbated by spontaneous breathing efforts and patient-ventilator dyssynchrony with a 
consequent increase in transpulmonary pressures (10-12). Tidal volume, plateau airway pressure, 
driving pressure, respiratory rate, inspiratory flow, and excessive positive end-expiratory 
pressure (PEEP) have all been implicated as contributors to VILI to varying degrees (4, 9, 13), 
though it remains unclear which of these parameters are most important in reducing injury. 
Driving pressure appears to be the ventilation variable that correlates most strongly with 
mortality (14), though a causal relationship between driving pressure and outcome has not been 
firmly established (14-17). Many of these factors have been incorporated into mathematical 
equations reflecting the amount of energy transferred from the ventilator to the respiratory 
system, referred to as ‘mechanical power’ (13).
Volume- and pressure-limited ventilation (tidal volume of 4-8 mL/kg predicted body weight, 
frequently referred to as “6 ml/kg” because that is the initial goal after stabilization, and plateau 
airway pressure of 30 cm H2O or less) and prone positioning have demonstrated survival benefits 
in ARDS (18-20), and have been recommended in recent clinical practice guidelines (21). 
Additional strategies, including high levels of PEEP, and, to a lesser degree, recruitment 
maneuvers may likewise be beneficial, although the efficacy of these approaches have been 
called into question given the results of a randomized controlled trial that found increased 
mortality in patients who received a lung recruitment and titrated PEEP strategy (16, 22, 23). 
Although the Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome 
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(ROSE) trial did not demonstrate a benefit from the addition of a fixed-dose, 48-hour infusion of 
neuromuscular blockade in patients with ARDS and a PaO2:FIO2 <150 mm Hg (24), the use of 
neuromuscular blockade may nonetheless be considered on an individualized basis, particularly 
in the setting of ventilator dyssynchrony (e.g. double-triggering), which may increase the 
propensity for VILI, or as needed for the implementation of prone positioning (25-28). Although 
not specifically addressed in this narrative review, a restrictive fluid management strategy may 
have additional benefits in ARDS (29).
Rationale for ultra-lung-protective ventilation
Data supporting ultra-lung-protective ventilation
Both preclinical and human data suggest VILI continues to occur during ARDS despite 
adherence to best practices conventional ventilator management (30-32). Animal models have 
highlighted the injurious effects of cyclic alveolar stretch, particularly at high tidal volumes or in 
the context of hyperoxemia (33-35). Frank et al. demonstrated that lung injury in a rat model of 
ARDS decreased when tidal volume was lowered from 12 mL/kg to 6 mL/kg, but lung injury 
appeared to be minimized even further when tidal volume was lowered to 3 mL/kg (30). Post 
hoc analysis of the Ventilation with lower tidal volumes as compared with traditional tidal 
volumes for acute lung injury and the acute respiratory distress syndrome (ARMA) trial 
suggests that there is a consistent correlation between lower tidal volumes, lower plateau airway 
pressures, and improved survival (31), and Needham and colleagues demonstrated that this 
relationship continues in a linear fashion below the traditional lung-protective tidal volume of 6 
mL/kg (32). 
Limitations in achieving ultra-lung-protective ventilation
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With no apparent lower limit to the mortality reduction associated with volume and pressure 
reductions during ARDS management (31, 32), it may be reasonable to conclude that tidal 
volumes and airway pressures should be reduced below the current standard of care in order to 
minimize VILI and maximize outcomes. If tidal volumes of 6 mL/kg (and corresponding plateau 
airway pressures of 30 cm H2O or less) are considered ‘lung-protective’ (18), then perhaps even 
lower tidal volumes (i.e. <4 mL/kg) and airway pressures (e.g. <25 cm H2O) should be referred 
to as ‘ultra-lung-protective’ ventilation. Respiratory rate, which from a VILI perspective may be 
viewed as the frequency with which the lung is exposed to injurious volumes and pressures, has 
likewise been proposed as a potential target for VILI reduction (13, 36, 37). 
The main physiological barrier to achieving ultra-lung-protective ventilation in some patients 
with ARDS (particularly those with the most severe forms of ARDS) is the development of 
intolerable respiratory acidosis, which in turn often necessitates a high respiratory rate that may 
or may not be sufficient to mitigate the acidemia and may itself add to VILI. In fact, in order to 
maintain acceptable pH during the application of even traditional low tidal volumes (6.2-6.5 
mL/kg) during the ARMA trial, respiratory rates were substantially higher (29-30 breaths per 
minute) than in the high tidal volume control group (16-20 breaths per minute) over the first 7 
days of the study (18). The use of extracorporeal gas exchange offers an opportunity to achieve 
ultra-lung-protective ventilation, including reductions in respiratory rate, while mitigating the 
resultant respiratory acidosis. Of course, not all patients require ECLS to achieve ultra-lung-
protective ventilation (38). However, without ECLS, this would be difficult to achieve in most 
patients with severe ARDS.
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ECMO and ECCO2R in ARDS
Indications for ECMO and ECCO2R
Venovenous extracorporeal membrane oxygenation (ECMO) and extracorporeal carbon dioxide 
removal (ECCO2R) are two related forms of ECLS that have the ability to support impairment in 
gas exchange (39). In both circumstances, venous blood is drained from a central vein via a 
cannula, pumped through a semipermeable membrane that permits diffusion of oxygen and 
carbon dioxide, and returned via a cannula to a central vein. ECMO, which uses high blood flow 
rates to both oxygenate the blood and remove carbon dioxide, may be considered in patients with 
severe ARDS with refractory hypoxemia or severe respiratory acidosis (1, 2). Because carbon 
dioxide removal is much more efficient than oxygenation, ECCO2R can be accomplished at 
relatively low blood flow rates, although this approach will not effectively improve oxygenation 
(Figure 2) (40, 41). Lower blood flow rates permit the use of smaller cannulae for ECCO2R than 
would be required for ECMO (42), which theoretically provides a safer risk profile when 
compared with ECMO from the perspective of cannula-associated complications. However, a 
need for higher levels of anticoagulation with ECCO2R as compared with ECMO given the 
lower blood flow rates (43), may be associated with higher -not lower- risks of complications 
(44, 45). The majority of ECCO2R is performed as venovenous but pumpless arteriovenous 
ECCO2R has also been reported, a method that introduces the additional risk of arterial 
cannulation and does not allow for the same degree of control of extracorporeal blood flow rates 
(46). 
ECMO is supported by an increasing body of literature justifying various thresholds for its use in 
severe ARDS for the management of marked impairments in gas exchange (1, 26, 47, 48). There 
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has been a steady rise in its use for these indications (49, 50). Identifying maximally protective 
ventilator management and gas exchange targets are essential to realizing the potential benefit of 
ECMO when it is employed in this context. In less severe ARDS, whether ECCO2R should be 
applied solely for the purpose of facilitating ultra-lung-protective ventilation is a subject of 
ongoing clinical investigation (Table E2) (40). More data is needed before one could recommend 
ECCO2R in less severe forms of ARDS for which ECMO itself is not otherwise indicated.
Ability of ECLS to facilitate ultra-lung-protective ventilation
In an experimental study, Grasso et al. demonstrated the feasibility and potential impact of using 
ECCO2R to achieve isolated reductions in respiratory rates (from 30.5 to 14.2 breaths per 
minute), with notable decreases in several inflammatory cytokines associated with VILI (36). 
Several prospective trials of ECLS in ARDS have demonstrated the feasibility of reducing 
various ventilator parameters while maintaining adequate gas exchange (36, 46, 51, 52). Most of 
these trials have employed ECCO2R but the results may be extrapolated to ECMO, which 
provides even greater gas exchange support. Terragni et al. used ECCO2R in ARDS patients to 
facilitate reductions in plateau airway pressures from 29.1 to 25.0 cm H2O (and tidal volumes 
from 6.3 to 4.2 mL/kg) while correcting the resultant respiratory acidosis, with an associated 
reduction in pulmonary inflammatory cytokines (51). The Xtravent study randomized 79 patients 
with moderate to severe ARDS to standard mechanical ventilation or ECCO2R-assisted ultra-
lung-protective ventilation: it achieved very low tidal volumes (3.4 mL/kg), with marked 
reductions in driving pressure, and maintaining normal pH without an increase in respiratory rate 
(Table 1) (46). 
A recent phase 2 international collaborative study of ECCO2R to facilitate ultra-lung-protective 
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ventilation was performed in 95 subjects with moderate ARDS. Reductions in tidal volumes 
from 6.0 mL/kg to 4.2 mL/kg, plateau airway pressures from 27.7 cm H2O to 23.9 cm H2O, and 
respiratory rates from 27.4 to 23.5 breaths per minute were achieved simultaneously, all while 
maintaining PaCO2 and pH within pre-defined acceptable ranges (Table 1) (52). The reductions 
in tidal volumes and airway pressures led to a decrease in driving pressure from an average of 
13.2 cm H2O to 9.9 cm H2O (p=0.001), while maintaining a similar level of PEEP. 
In the context of clinical practice, retrospective studies, patient-level meta-analyses, and a 
prospective multicenter study of high-volume ECLS centers all corroborate the findings of the 
aforementioned feasibility studies, wherein ECLS initiation is typically accompanied by 
reductions in tidal volume, plateau airway pressure, driving pressure, respiratory rate, and FIO2, 
with variable changes to PEEP and preservation of gas exchange (Table 1) (53-56). The 
LIFEGARDS international observational study enrolled 350 patients supported by ECLS across 
23 intensive care units with experience in ECLS. An ultra-lung-protective ventilation strategy 
was largely applied: driving pressure was maintained ≤15 cm H2O, correlating with a decrease in 
mechanical power from 26.1±12.7 pre-ECLS to 6.6±4.8 J/min during ECLS (56). Mechanical 
ventilation settings during the first 2 days of ECLS were not associated with mortality, in 
contrast with previous observations that suggested that decreased driving pressure and increased 
PEEP early in the course of ECLS were independently associated with reduced mortality (53, 
54). This lack of association between early mechanical ventilation settings and outcomes 
indirectly suggests that once ultra-lung-protective ventilation, i.e., low driving pressure and very 
low power, has been efficiently implemented, the residual ventilation does not substantially 
influence outcome. A time-varying Cox model identified higher tidal volume and lower driving 
pressure over the duration of ECLS support, implying progressive improvement in static 
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respiratory system compliance, as being independently associated with lower 6-month mortality. 
Optimizing ventilator settings during ECLS for ARDS
There are no large, prospective clinical trials comparing different ventilator strategies during 
ECLS for ARDS, and thus no definitive standard of care exists. Available data, however, might 
offer valuable insights into what might be considered current best practices. 
A pre-clinical swine study investigating the effect of mechanical ventilation strategies on lung 
injury in ARDS supported with ECMO, found that a ventilator strategy with very low airway 
pressures, tidal volumes, and respiratory rates (PEEP 10 cm H2O, driving pressure 10 cm H2O, 
tidal volume of approximately 2 mL/kg, respiratory rate of 5 breaths per minute) led to less 
histologic lung injury than so-called nonprotective (PEEP 5 cm H2O, tidal volume 10 mL/kg, 
respiratory rate of 20) or conventional protective (PEEP 10 cm H2O, tidal volume 6 mL/kg, 
respiratory rate of 20) approaches (57). 
A recent single-center, randomized, crossover trial provides pilot data on the effect of ultra-lung-
protective ventilation (maximum plateau airway pressure of 24 cm H2O) with various 
combinations of PEEP (range 5-20 cm H2O) and driving pressure (range 4-19 cm H2O) on 
inflammatory cytokines in 16 patients receiving ECMO for severe ARDS (58). Compared to pre-
ECMO standard of care conventional ventilation, strategies that combined higher PEEP with 
lower driving pressure demonstrated significant reductions in both plasma IL-6 and soluble 
receptor for advanced glycation end-products (sRAGE). Of note, driving pressures of 12 and 4 
cm H2O correlated with mean tidal volumes of 3.3 and 1.5 mL/kg, respectively, despite which 
pH and PaCO2 levels were maintained within the normal range.
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The most rigorous controlled data for major clinical outcomes with ECMO in severe ARDS 
comes from the EOLIA trial (1), which in combination with a post hoc Bayesian analysis (47) 
and a systematic review with meta-analysis (48), suggest improved mortality in those supported 
with ECMO compared with patients receiving best practice conventional management strategies. 
The ventilator strategy used in EOLIA during ECMO limited plateau airway pressure to a 
maximum of 24 cm H2O in conjunction with PEEP ≥10 cm H2O (corresponding to a driving 
pressure of 14 cm H2O or less), respiratory rate of 10 to 30 breaths per minute, and FIO2 of 0.3-
0.5 (Table E1) (1). The subgroup of EOLIA with the greatest reduction in mortality consisted of 
those patients enrolled because of excessive ventilatory pressures and respiratory acidosis, rather 
than for hypoxemia, although randomization was not stratified by inclusion criteria. It seems 
reasonable to propose that ECMO-supported patients be managed with ventilator settings that do 
not exceed the parameters used in the EOLIA trial, or, alternatively, the CESAR trial, whose 
ECMO-facilitated ventilator settings were similar to those of EOLIA and whose data were 
included in the systematic review with meta-analysis (3, 48). Given the impact of tidal volume, 
driving pressure and possibly respiratory rate on VILI, and the relative ease with which these 
variables can be reduced during ECMO, it may be advantageous to target lower volumes, 
pressures and respiratory rates beyond those used in EOLIA (Table 3) but this remains unproven. 
It is similarly unclear what the optimal PEEP is for patients receiving ECLS, and may require 
individualization based on a given patient’s alveolar recruitability, pleural pressure, and 
hemodynamics (59). In the absence of data to the contrary, again a PEEP of at least 10 cm H2O 
may be reasonably proposed based on the favorable outcomes with the strategy used in EOLIA, 
with consideration for higher PEEP with morbid obesity. Beyond this, whether apneic 
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oxygenation (i.e. optimized PEEP with no respiratory rate or driving pressure, so-called 
‘maximal lung rest’) is better than tidal ventilation has yet to be determined. 
While ultra-lung-protective ventilation appears to be both achievable and beneficial for patients 
receiving ECLS for ARDS, the optimal targets of these parameters, how best to individualize 
these settings, how long to stay within the limits of these targets, whether adjunctive therapies 
(e.g. prone positioning, neuromuscular blockade) may be of additional benefit, when to wean 
patients from extracorporeal support, and the impact of these strategies on long-term outcomes 
are all areas that require further investigation (Table 2) (21, 60-63). Ongoing and upcoming 
randomized controlled trials may provide further insight into several of these topics (Table E2). 
Prone positioning during ECLS, which is the subject of a multicenter trial in the planning phase, 
is one area of particular interest given that there is robust data for prone positioning during 
conventional ARDS management. However, the physiological effects of prone positioning may 
not necessarily be as impactful when ultra-lung-protective ventilation, and thus very low tidal 
volume, is applied, and there is added risk of ECLS cannula dislodgement during the maneuver 
itself. A study matching patients receiving prone positioning during ECMO for ARDS with those 
not receiving prone positioning suggested a benefit from being in the prone position. However, 
this practice remains investigational pending further evidence (64). Future trials of mechanical 
ventilation during ECLS for ARDS may benefit from enriching study populations with patients 
whose physiological parameters would suggest the greatest likelihood of detecting a response 
from the intervention (65). 
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Gas exchange targets during ECLS for ARDS
Recommendations
There are no evidence-based guidelines for the management of oxygenation, carbon dioxide, or 
pH in patients with ARDS supported with ECLS, and safe limits of hypoxemia and hypercapnia 
have not been firmly established. In the absence of data to the contrary, it is reasonable to use the 
gas exchange targets implemented in the EOLIA trial (PaO2 65 to 90 mm Hg; PaCO2 below 45 
mm Hg) (1) as a default approach during ECLS until more specific data addressing these 
parameters are obtained. Previously established values from studies using conventional 
management strategies, including the ARMA approach, may also be appropriate (see Table E1 in 
the online data supplement) (18, 66). 
Potential consequences of extremes in oxygen and carbon dioxide
Existing data have called attention to uncertainty about the tolerable lower and upper limits of 
oxygenation (67, 68), both of which may be relevant for patients receiving ECMO. Retrospective 
observational data of patients receiving venovenous ECMO for respiratory failure suggest 
increased mortality associated with both moderate hyperoxemia (PaO2 101-300 mm Hg) and 
hypoxemia (PaO2 <60 mm Hg) 24 hours after ECMO initiation compared to near-normal 
oxygenation (PaO2 60-100 mm Hg) (69). Other data suggest that the neurocognitive impact from 
prolonged hypoxemia (e.g. SpO2 80% for up to 10 days) during ECLS for ARDS might be 
limited so long as tissue hypoxia (as assessed by blood lactate levels) is avoided (70, 71). 
However, such data must only be considered hypothesis generating for future studies.
Page 18 of 55 AJRCCM Articles in Press. Published on 14-November-2019 as 10.1164/rccm.201907-1283CI 
 Copyright © 2019 by the American Thoracic Society 
An association between hyperoxemia (PaO2 >200 mm Hg) within the first 48 hours of ECLS 
initiation and increased mortality was also identified in a pediatric ECMO cohort, although this 
analysis was not limited to patients with respiratory failure and involved both venovenous and 
venoarterial ECLS (72). The same study reported an association between PaCO2 <30 mm Hg 
within the first 48 hours of ECLS and an increased rate of neurological events (72). Of note, the 
rapidity with which carbon dioxide is reduced after ECLS initiation has been implicated in the 
development of neurological complications and is an area that warrants further study (73). 
Special considerations for gas exchange during ECLS: Hypoxemia under ECMO
The degree to which ventilator settings can be reduced while targeting oxygenation and 
ventilation goals will depend predominantly on the amount of carbon dioxide removal and 
oxygenation achieved via the extracorporeal circuit, in addition to the tolerance for accepting 
deviations from pre-specified gas exchange targets. Certain physiological effects of ECLS on gas 
exchange may pose challenges to achieving these targets and warrant particular consideration.
In venovenous ECMO, extracorporeal gas exchange is provided in series with native gas 
exchange – well-oxygenated blood returned to the venous system from the ECMO circuit then 
passes through the native pulmonary circulation prior to reaching the systemic circulation. The 
contribution of ECMO to systemic oxygenation is dependent on the proportion of extracorporeal 
blood flow (QE) relative to systemic blood flow (QS); the greater the percentage of cardiac output 
passing through the circuit, the greater the contribution to systemic oxygenation (Figure 3) (39, 
41). This configuration has certain physiological consequences that determine whether 
mechanical ventilation is still required for gas exchange. Delivery of blood with high oxygen 
content to the pulmonary vasculature will attenuate the hypoxemic vasoconstriction associated 
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with regions of the lung with low ventilation-perfusion ratios, which in turn may reduce right 
ventricular afterload and improve right ventricular function (74). However, in cases where there 
is residual native lung function, the consequent pulmonary vasodilation may also increase the 
shunt fraction through the native lung, potentially diminishing the benefit derived from ECMO in 
terms of oxygenation (75). 
High ECMO blood flow rates relative to native cardiac output (QE/QS) -- which in turn requires 
larger ECMO cannulae -- along with minimization of recirculation (oxygenated blood taken back 
up by the extracorporeal circuit without having passed through the systemic circulation) may 
therefore be necessary to provide sufficient gas exchange to achieve additional lung-protective 
ventilation (42, 76). Methods to reduce recirculation to maximize systemic oxygenation have 
been described elsewhere (76). 
Special considerations for gas exchange during ECLS: Hypoxemia under ECCO2R
By contrast, ECCO2R does not contribute meaningfully to oxygenation and may in fact 
exacerbate hypoxemia, requiring increases in PEEP and FIO2. There are two major mechanisms 
by which ECCO2R may lead to hypoxemia. If ECCO2R is used to achieve a decreased tidal 
volume, the lower tidal volume will lead to a decrease in tidal recruitment and mean airway 
pressure resulting in worsened atelectasis and an increase in shunt fraction. This could be offset 
by an increase in PEEP to recruit lung units and increase oxygenation. 
The second mechanism of hypoxemia is more complex and pertains to the reduction in native 
lung alveolar ventilation in response to the addition of ECCO2R, if maintaining a constant partial 
pressure of carbon dioxide in arterial blood (PaCO2) (77, 78). Assume that carbon dioxide 
elimination is 200 mL/min through alveolar ventilation, and that ECCO2R is able to remove 100 
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mL/min. If maintaining steady state PaCO2, the addition of ECCO2R will cause native lung 
alveolar ventilation to be reduced by half (from 200 mL/min to 100 mL/min), resulting in a 
marked reduction in the partial pressure of oxygen in the alveoli (PAO2), and, by extension, the 
partial pressure of oxygen in arterial blood (PaO2). These changes are reflected in the alveolar 
gas equation: 
PAO2 = (Patm – PH2O) x FIO2 – PaCO2/RER
where RER (respiratory exchange ratio) represents the relationship between carbon dioxide 
elimination (VCO2) and oxygen uptake (VO2) within the lung. RER is defined as VCO2/VO2. In 
the presence of ECCO2R, VCO2 within the alveolar gas equation is now equal to native lung 
VCO2 (VCO2NL) minus VCO2 accomplished by the ECCO2R membrane (referred to as 
VCO2ML): 
PAO2 = (Patm – PH2O) x FIO2 – PaCO2/[(VCO2NL-VCO2ML)/VO2]
Assuming a typical RER of 0.8 (VCO2NL = 200 ml/min, VO2 = 250 ml/min), an extracorporeal 
circuit with a VCO2ML of 100 mL/min will lead to a halving of the RER (0.4, i.e. (200-
100)/250, assuming that the oxygen added to the circulation by the extracorporeal circuit is 
negligible). According to the alveolar gas equation, this decrease in RER would lead to a marked 
decrease in PAO2, which can be “corrected” by increasing FIO2 (77, 78). Such an effect on PAO2 
may also be mitigated by targeting a lower PaCO2, rather than maintaining it at the pre-ECCO2R 
level, thereby reducing PaCO2 in proportion to the RER.
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Additional areas for research
The role of spontaneous breathing
Up to this point, the discussion on optimal ventilator management during ECLS for ARDS has 
focused on the application of controlled mechanical ventilation with limits on airway pressures, 
tidal volumes, and respiratory rates. Whether the allowance of spontaneous breathing, with or 
without ventilator support, during ECLS affords net benefit or harm likely depends, in part, on 
the patient’s respiratory pattern, patient-ventilator dyssynchrony, pendelluft, the phase and 
duration of ARDS, and biological predisposition to mechanical injury (79). Vigorous 
spontaneous breathing with excessive tidal volumes and minute ventilation can lead to worsened 
lung injury through excessive transpulmonary pressure and transmural pulmonary vascular 
pressure, so-called patient self-inflicted lung injury (P-SILI) (10, 11, 79, 80). One cannot, 
therefore, simply assume that patients breathing spontaneously are protected from worsening 
lung injury, especially when the patient's drive to breath is substantial. 
The use of deep sedation (with or without neuromuscular blockade) during invasive mechanical 
ventilation may diminish patient-ventilator dyssynchrony and allow for full control of invasive 
mechanical ventilation (12), yet such an approach exposes patients to greater risk of 
diaphragmatic atrophy and adverse effects of increased doses of these drugs (e.g. delirium, 
inability to participate in physical therapy, delayed transition to spontaneous breathing, liberation 
from invasive mechanical ventilation) (7). In addition, increased sedation can actually lead to 
worsening of some types of patient-ventilator dyssynchrony (e.g. reverse triggering) (81, 82). 
Allowing for patient inspiratory effort during invasive mechanical ventilation may reduce the 
risks of sedative and neuromuscular blocking agents and allow for greater preservation of 
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respiratory and peripheral muscle strength (83, 84), but in some patients may increase the risk of 
lung injury (12). How best to identify the optimal balance between minimizing sedation and 
avoiding VILI is unclear.
Extracorporeal support offers a potential means of controlling respiratory drive in select 
spontaneously breathing patients, and has been demonstrated with variable success in ARDS 
patients (85, 86). Titrating carbon dioxide removal to achieve an acceptable respiratory drive 
offers an opportunity to maintain safe spontaneous breathing – i.e. patient respiratory efforts that 
do not lead to unsafe dynamic stress and strain within the lung. This would alleviate the need for 
sedation and paralysis, permit the maintenance of respiratory effort to minimize diaphragm 
atrophy and avoid the neurocognitive sequelae of heavy sedation. The feasibility of such 
regulation may also depend on the extent to which respiratory drive is subject to chemoreflex 
control, which in turn may depend on the duration and severity of ARDS. Such control, if 
feasible, opens the possibility of endotracheal extubation during extracorporeal support, which in 
turn would eliminate VILI altogether. Whether an initial strategy of ECLS and extubation (or 
avoidance of intubation) for ARDS is more favorable than controlled mechanical ventilation 
(with or without ECLS) has yet to be determined. 
Weaning from mechanical support
For patients receiving both mechanical ventilation and ECLS who are recovering from ARDS 
and ready to wean from device support, whether to first decannulate or extubate depends on 
individual patient circumstances and clinical judgment, as there are no high quality data to guide 
decision-making. Those suffering from or at higher risk of developing ECLS complications (e.g. 
bleeding, hemolysis, infection) may benefit from decannulation before extubation, whereas 
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others at greater risk of ventilator-associated complications (e.g. patients with pneumothorax) or 
who require substantial amounts of sedation solely to maintain ventilator synchrony may benefit 
from a strategy that favors endotracheal extubation first. 
 Conclusion
The overall goal of invasive mechanical ventilation during ECLS for ARDS should be to 
decrease its intensity with the aim of reducing VILI and maximizing the potential benefit of 
ECLS. Precisely how particular ventilator variables should be adjusted has yet to be determined. 
In the interim, the EOLIA ventilator protocol during ECMO is a reasonable new minimum 
standard. Future studies should focus on more precisely delineating the best strategies for 
optimizing invasive mechanical ventilation during ECLS for ARDS. 
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Figure legends
Figure 1. Potential effects of ECLS on VILI. Panel A. Invasive mechanical ventilation may cause 
VILI through multiple mechanisms, including atelectrauma, barotrauma, volutrauma, 
myotrauma, and biotrauma. Panel B. The addition of ECLS allows for reductions in many of the 
contributors to VILI, through decreases tidal volume, respiratory rate, driving pressure, and 
plateau airway pressure, while maintaining adequate gas exchange. The effect on certain 
parameters, such as myotrauma, will depend on the patient’s respiratory effort and synchrony 
between the patient and ventilator. ECLS may help reduce myotrauma by minimizing excess 
respiratory drive. ECLS extracorporeal life support; VILI ventilator-induced lung injury; VT tidal 
volume; Pplat plateau airway pressure; RR respiratory rate; ΔP driving pressure; TNF-a tumor 
necrosis factor alpha; IL-6 interleukin 6; IL-8 interleukin 8; IL-1B interleukin 1 beta. Illustration 
created by Savannah Soenen.
Figure 2. Mathematical model demonstrating the relationship between ECLS blood flow, cardiac 
output, oxygen delivery, and carbon dioxide removal through the membrane lung. Maximal rates 
of carbon dioxide removal can be achieved at relatively low blood flow rates compared to those 
needed for oxygen delivery. Panel A: Rates of carbon dioxide removal and oxygen delivery at a 
cardiac output of 5 L/min. Near-total carbon dioxide removal is achieved at an ECLS blood flow 
rate of approximately 3 L/min. Panel B: Rates of carbon dioxide removal (VCO2ML) and 
oxygen delivery (VO2ML) through the membrane lung at a cardiac output of 8 L/min. Near-total 
carbon dioxide removal is achieved at an ECLS blood flow rate of approximately 5 L/min. This 
model assumes a sweep gas flow rate of 10 L/min, fraction of inspired oxygen (FIO2) of 1.0, 
fraction of delivered oxygen to the membrane lung (FDO2) of 1.0, total carbon dioxide 
production of 200 mL/min, total oxygen consumption of 250 mL/min, partial pressure of carbon 
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dioxide (PaCO2) maintained at 40 mmHg, hemoglobin of 10 g/dL, and recirculation of 15%. 
Graphs derived from www.ecmomodel.unimi.it courtesy of Alberto Zanella and Antonio Pesenti 
based on a previously published mathematical model (40).
Figure 3. Mathematical model demonstrating the relationship between ECLS blood flow, cardiac 
output, and arterial oxygen saturation. An increase in the ECLS blood flow-to-cardiac output 
ratio (QE/QS) leads to an increase in arterial oxygen saturation. This model assumes a shunt 
fraction of 100%, fraction of delivered oxygen to the membrane lung of 1.0, hemoglobin of 10 
g/dL, and recirculation of 15%. Shaded blue bar: potential target arterial oxygen saturation 
during ECLS support. CO cardiac output. Graphs derived from www.ecmomodel.unimi.it 
courtesy of Antonio Pesenti based on a previously published mathematical model (40).
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Table 1. Ventilatory parameters before and after ECLS initiation in studies of ECLS for ARDS  
ECLS extracorporeal life support; VT Tidal volume; PBW predicted body weight; RR respiratory rate; MVE minute ventilation; PEEP 
positive end-expiratory pressure; Pplat plateau airway pressure; ΔP driving pressure; Crs respiratory system compliance; FIO2 fraction of 
inspired oxygen; PaCO2 arterial partial pressure of carbon dioxide; PaO2 arterial partial pressure of oxygen; QE extracorporeal blood 
flow rate
*average over days 1-3 of ECLS
†at 24hrs of ECLS
‡within first 2 days of ECLS
Retrospective studies Prospective studies
Schmidt (54) Marhong (55) Serpa Neto 
(53)
Xtravent (46) EOLIA (1) SUPERNOVA 
(52)
LIFEGARDS 
(56)
Pre Post* Pre Post† Pre Post† Pre Post† Pre Post† Pre Post† Pre Post‡
VT (mL/kg 
PBW)
6.3 3.9 6.1 3.9 6.0 4.0 5.9 3.4 6.0 3.4 6.0 4.2 6.4 3.7
RR (bpm) 22.0 15.0 - - 21.9 17.8 22.4 22.2 30.4 23.1 27.4 23.5 26 14
MVE 
(L/min)
8.8 3.6 - - 9.1 5.0 9.9 5.8 - - 10.2 5.9 10.2 3.5
PEEP 
(cmH2O)
13.0 12.0 14.0 12.0 13.7 12.9 16.1 17.1 11.7 11.2 13.6 14 12 11
Pplat 
(cmH2O)
32.2 26.4 32 25.5 31.1 26.2 29.0 25.1 29.8 24.4 27.7 23.9 32 24
ΔP (cmH2O) 19 13.7 18 13.5 17.7 13.7 12.9 8.0 17.8 13.2 13.2 9.9 20 14
Crs 
(mL/cmH2O)
23.2 19.9 22.7 19.4 26.8 23.2 34.4 32.2 25.0 20.1 - - 24 19
FIO2 0.96 0.60 0.99 0.40 0.90 0.69 0.62 0.54 0.96 0.50 - - 1.0 0.5
PaCO2 
(mmHg)
66.0 40.5 - - 58.3 40.3 57.3 53.9 57 38 48 46.7 68 42
pH 7.24 7.41 - - 7.27 7.39 7.34 7.38 7.24 7.37 7.34 7.39 7.24 7.4
PaO2:FIO2 
(mmHg)
67.0 - 61.0 - 72.6 152.5 152 154.5 73 - 168 168 71 -
QE (L/min) - 4.5 - 3.0 - 4.3 - 1.3 - 5.0 - 0.4 - 4.2
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Table 2. Suggested areas of future research for ECLS in ARDS
Ventilator settings
Which ventilator parameters are most predictive of outcomes in ARDS?
How should PEEP be titrated, and is there a role for recruitment maneuvers during ECLS?
Adjunctive therapies
Is there a role for neuromuscular blockade during ECLS?
Is there a role for prone positioning during ECLS?
Gas exchange targets during ECLS
What are optimal oxygen, carbon dioxide, and pH targets during ECLS support? 
What is the impact of hyperoxemia during ECLS?
What is the consequence, if any, of rapid changes in carbon dioxide?
Spontaneous breathing
Which factors influence respiratory drive in ARDS patients receiving ECLS?
Should we allow for spontaneous breathing during ECLS?
If so, does the timing matter, relative to the onset of ARDS?
Should mechanical ventilation be maintained during ECLS?
If so, which should be weaned first, ECLS or mechanical ventilation?
Can ECLS facilitate a lung and diaphragm-protective ventilation strategy? 
How can we determine which patients require ECLS for this strategy?
ARDS acute respiratory distress syndrome; ECCO2R extracorporeal carbon dioxide removal; ECLS extracorporeal 
life support; PEEP positive end-expiratory pressure
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Table 3. Suggested initial mechanical ventilation targets during ECLS for ARDS
Parameter Target Notes
Plateau pressure (PPlat)1 ≤ 24 cm H2O, may choose to go 
lower, if feasible
Driving pressure (ΔP)1 ≤ 14 cm H2O
Tidal volume Adjust for goal PPlat Typically ≤ 4ml/kg PBW, often much 
lower
Respiratory rate2 ≤ 10 breaths per minute Typically only achieved when sedation, 
with or without NMBAs, is being used. 
Consider increased sweep flow to 
achieve, when appropriate
PEEP1 ≥ 10 cm H2O See text for circumstances that may 
warrant particularly high levels of PEEP 
FIO21 0.3 to 0.5 Higher FIO2 may be necessary if ECLS 
is inadequate at achieving acceptable 
levels of oxygenation 
Adequate oxygen delivery is the primary 
goal, not a particular SaO2
1These recommended targets are based on the ventilator protocol of the intervention arm of the EOLIA trial
2The recommendation for respiratory rate below the lower limit of the EOLIA protocol is based on the presumption that lower respiratory rates are 
both more protective and achievable during ECLS 
ARDS acute respiratory distress syndrome; ECLS extracorporeal life support; EOLIA Extracorporeal Membrane Oxygenation for Acute 
Respiratory Distress Syndrome; FIO2 fraction of inspired oxygen; NMBAs neuromuscular blocking agents; ΔP driving pressure; PBW predicted 
body weight; PEEP positive end-expiratory pressure; PPlat plateau airway pressure; SpO2 arterial oxygen saturation 
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Table E1. Comparison of ventilator parameters and gas exchange goals between the intervention 
arms of the ARMA and EOLIA trials 
*The ventilator parameters and gas exchange goals described were applied to patients receiving ECMO 
in the EOLIA trial. Both volume-assist control and APRV were acceptable ventilator modes
†As defined by the American-European Consensus Conference Definition 
‡Despite optimized conventional VT 6 mL/kg PBW, PEEP ≥ 10 cm H2O, and FIO2 ≥ 0.8
4§Neuromuscular blockade and prone positioning strongly encouraged
llWith respiratory rate increased to 35 breaths per minute and mechanical ventilation settings adjusted to 
keep a plateau airway pressure of ≤32 cm of water 
**This mode was not traditional APRV (airway pressure release ventilation), but rather a non-
synchronized form of bilevel positive airway pressure with a maximum pressure of 24 cmH2O, a 
minimum PEEP of 10 cmH2O and a respiratory rate of 10-30. An inspiratory-to-expiratory ratio of 1:2 
was recommended
††Increases in PEEP up to 34 cm H2O were permitted 
APRV airway pressure release ventilation; ARDS acute respiratory distress syndrome; ARMA Ventilation 
with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute 
respiratory distress syndrome; EOLIA Extracorporeal membrane oxygenation for severe acute respiratory 
distress syndrome; FIO2 fraction of inspired oxygen; PaCO2 partial pressure of carbon dioxide in arterial 
blood; PaO2 partial pressure of oxygen in arterial blood; PEEP positive end-expiratory pressure; Phigh 
airway pressure during inspiratory phase of APRV; Pplat plateau airway pressure; SaO2 oxygen saturation in 
arterial blood; V-AC volume-assist control ventilation; VT tidal volume
ARMA EOLIA*
Inclusion criteria ARDS† (any severity) ARDS† with any of the following:
PaO2:FIO2 < 50 mmHg for > 3 hours‡,§
PaO2:FIO2 < 80 mmHg for > 6 hours‡,§
pH < 7.25 with PaCO2 ≥ 60 mmHg for > 6 hours‡,§,ll
Ventilatory Mode Any V-AC “APRV”**
VT and Pplat goals VT (8 mL/kg PBW or less) 
for Pplat ≤ 30 cmH2O
VT for Pplat ≤ 24 
cmH2O
Phigh ≤ 24 cmH2O
Respiratory Rate 
(breaths/min)
≤ 35 10-30
FIO2 0.3-1.0 0.3-0.5
PEEP (cmH2O) 5 – 24†† ≥ 10
Oxygenation goal PaO2 55-80 mmHg
SaO2 88-95%
PaO2 65-90 mmHg
SaO2 > 90%
pH or PaCO2 goals pH 7.30-7.45 PaCO2 < 45 mmHg
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Table E2. Ongoing studies of mechanical ventilation strategies during ECLS in ARDS
Title Study design Brief description Primary outcome
pRotective vEntilation 
With Veno-venouS 
Lung assisT in 
Respiratory Failure 
(REST);
NCT 02654327
Multicenter 
randomized 
controlled trial
Standard of care lung-
protective ventilation 
versus ECCO2R + ultra 
lung-protective 
ventilation 
90-day mortality
Strategies for Optimal 
Lung Ventilation in 
ECMO for ARDS: The 
SOLVE ARDS Study; 
NCT01990456 
Single-center non-
randomized 
crossover study
Varying tidal ventilation 
and PEEP strategies
Serum cytokines and 
physiologic parameters
Low Frequency, Ultra-
low Tidal Volume 
Ventilation in Patients 
with ARDS and VV-
ECMO; NCT03764319
Single-center 
randomized 
controlled trial
ECMO + standard of 
care lung-protective 
ventilation versus 
ECMO + ultra-
protective settings
Ventilator-free days at day 28 
of ECMO
Ultra-protective 
Pulmonary Ventilation 
Supported by Low 
Flow Extracorporeal 
Carbon Dioxide 
Removal (ECCO2R) 
and Prone Positioning 
for ARDS; a Pilot 
Study; NCT02252094
Single-center 
randomized 
controlled trial
Standard of care lung-
protective mechanical 
ventilation versus 
ECCO2R + ultra lung-
protective ventilation
Ability to achieve plateau 
pressure ≤ 25 cmH2O in the 
ECCO2R arm
Enhanced Lung 
Protective Ventilation 
With Extracorporeal 
CO2 Removal During 
Acute Respiratory 
Distress Syndrome; 
NCT03525691 
Single-center 
randomized 
crossover trial
Standard of care lung-
protective ventilation 
versus ECCO2R + two 
different ultra lung-
protective ventilation 
strategies
Change in PaCO2 after 
initiation of ECCO2R
ARDS acute respiratory distress syndrome; ECCO2R extracorporeal carbon dioxide removal; ECMO 
extracorporeal membrane oxygenation; PaCO2 partial pressure of carbon dioxide in arterial blood; PEEP 
positive end-expiratory pressure; VV venovenous
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Descriptions of studies listed in Table 1
Schmidt M, Stewart C, Bailey M, Nieszkowska A, Kelly J, Murphy L, Pilcher D, 
Cooper DJ, Scheinkestel C, Pellegrino V, Forrest P, Combes A, Hodgson C. 
Mechanical ventilation management during extracorporeal membrane oxygenation 
for acute respiratory distress syndrome: a retrospective international multicenter 
study. Crit Care Med 2015; 43: 654-664.
Study design: Retrospective observational study.
Patients: 168 patients receiving venovenous ECMO for ARDS at 3 high-volume ECMO 
centers.
Methods: Analysis of association between mechanical ventilation settings and ICU 
mortality.
Main results: Higher PEEP during the first 3 days of ECMO was found to be associated 
with lower ICU mortality in multivariate analysis.
Marhong JD, Munshi L, Detsky M, Telesnicki T, Fan E. Mechanical ventilation 
during extracorporeal life support (ECLS): a systematic review. Intensive Care Med 
2015; 41: 994-1003.
Study design: Systematic review.
Patients: 2,042 patients receiving ECLS (all forms) for ARDS.
Methods: Analysis of change in mechanical ventilation settings after the initiation of 
ECLS.
Main results: Tidal volume, plateau airway pressure, PEEP, and FIO2 are commonly 
reduced after initiation of ECLS.
Serpa Neto A, Schmidt M, Azevedo LC, Bein T, Brochard L, Beutel G, Combes A, 
Costa EL, Hodgson C, Lindskov C, Lubnow M, Lueck C, Michaels AJ, Paiva JA, 
Park M, Pesenti A, Pham T, Quintel M, Marco Ranieri V, Ried M, Roncon-
Albuquerque R, Jr., Slutsky AS, Takeda S, Terragni PP, Vejen M, Weber-Carstens 
S, Welte T, Gama de Abreu M, Pelosi P, Schultz MJ, Re VARN, the PNI. 
Associations between ventilator settings during extracorporeal membrane 
oxygenation for refractory hypoxemia and outcome in patients with acute 
respiratory distress syndrome: a pooled individual patient data analysis : 
Mechanical ventilation during ECMO. Intensive Care Med 2016; 42: 1672-1684.
Study design: Individual patient data meta-analysis.
Patients: 545 patients receiving venovenous ECMO for refractory hypoxemia in the 
setting of ARDS.
Methods: Analysis of relationship between ventilator settings within the first 3 days of 
ECMO and in-hospital mortality. 
Main results: Initiation of ECMO was associated with significant decreases in tidal 
volume, PEEP, plateau airway pressure, driving pressure, respiratory rate, and minute 
ventilation, although only driving pressure was independently associated with mortality.
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Xtravent: Bein T, Weber-Carstens S, Goldmann A, Muller T, Staudinger T, 
Brederlau J, Muellenbach R, Dembinski R, Graf BM, Wewalka M, Philipp A, 
Wernecke KD, Lubnow M, Slutsky AS. Lower tidal volume strategy ( 
approximately 3 ml/kg) combined with extracorporeal CO2 removal versus 
'conventional' protective ventilation (6 ml/kg) in severe ARDS: the prospective 
randomized Xtravent-study. Intensive Care Med 2013; 39: 847-856.
Study design: Randomized, controlled trial.
Patients: 79 patients with moderate to severe ARDS.
Methods: Randomization to conventional low tidal volume ventilation (6 mL/kg) or very 
low tidal volume ventilation (3 mL/kg) plus ECCO2R . Primary outcome was ventilator-
free days (VFDs) at 28 and 60 days.
Main results: No overall difference in VFDs, although a significant difference in VFDs at 
60 days was seen among those with PaO2:FIO2 ≤150 mmHg in post hoc analysis.  
EOLIA: Combes A, Hajage D, Capellier G, Demoule A, Lavoue S, Guervilly C, Da 
Silva D, Zafrani L, Tirot P, Veber B, Maury E, Levy B, Cohen Y, Richard C, Kalfon 
P, Bouadma L, Mehdaoui H, Beduneau G, Lebreton G, Brochard L, Ferguson ND, 
Fan E, Slutsky AS, Brodie D, Mercat A, Eolia Trial Group R, Ecmonet. 
Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress 
Syndrome. N Engl J Med 2018; 378: 1965-1975.
Study design: Randomized, controlled trial.
Patients: 249 patients with severe ARDS who met one of the following inclusion criteria 
after optimization of conventional management (e.g. low tidal volume ventilation, 
neuromuscular blockade, prone positioning): PaO2:FIO2 < 50 mm Hg for > 3 hours; 
PaO2:FIO2 < 80 mm Hg for > 6 hours; or arterial blood pH < 7.25 with a PaCO2 ≥ 60 mm 
Hg for > 6 hours.
Methods: Randomization to ongoing conventional treatment or venovenous ECMO. 
Primary endpoint was 60-day mortality.
Main results: No statistically significant difference in 60-day mortality (ECMO group 
35%, control group 46%, relative risk, 0.76; 95% confidence interval [CI], 0.55 to 1.04; 
p=0.09). Thirty-five patients (28%) crossed over from control to ECMO for refractory 
hypoxemia, with an associated mortality of 57%. 
SUPERNOVA: Combes A, Fanelli V, Pham T, Ranieri VM, European Society of 
Intensive Care Medicine Trials G, the "Strategy of Ultra-Protective lung ventilation 
with Extracorporeal CORfN-OmtsAi. Feasibility and safety of extracorporeal CO2 
removal to enhance protective ventilation in acute respiratory distress syndrome: 
the SUPERNOVA study. Intensive Care Med 2019; 45: 592-600.
Study design: Prospective multicenter phase 2 study.
Patients: 95 patients with moderate ARDS.
Methods: Initiation of ECCO2R to target ultra-lung-protective ventilation (tidal volume of 
4 mL/kg and plateau airway pressure of ≤ 25 cmH2O, respectively. The primary endpoint 
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was the proportion of patients achieving ultra-lung-protective ventilation with PaCO2 
being maintained within 20% of baseline and arterial pH > 7.30.
Main results: 78% and 82% of patients achieved ultra-lung-protective ventilation by 8 
and 24 hours, respectively. ECCO2R-related adverse events were reported in 39% of 
patients.
LIFEGARDS: Schmidt M, Pham T, Arcadipane A, Agerstrand C, Ohshimo S, 
Pellegrino V, Vuylsteke A, Guervilly C, McGuinness S, Pierard S, Breeding J, 
Stewart C, Ching SSW, Camuso JM, Stephens RS, King B, Herr D, Schultz MJ, 
Neuville M, Zogheib E, Mira JP, Roze H, Pierrot M, Tobin A, Hodgson C, Chevret 
S, Brodie D, Combes A, International EN, the LSG. Mechanical Ventilation 
Management during ECMO for ARDS: An International Multicenter Prospective 
Cohort. Am J Respir Crit Care Med 2019.
Study design: Prospective cohort study.
Patients: 350 patients receiving venovenous ECMO for severe ARDS.
Interventions: Analysis of the association between mechanical ventilation practices and 
6-month outcomes.
Main results: Ultra-lung-protective ventilation, as practiced through reductions in tidal 
volume, plateau airway pressure, driving pressure, and respiratory rate, is commonly 
applied to patients receiving venovenous ECMO for severe ARDS at medium to high-
volume ECMO centers. No association was found between ventilator settings during the 
first 2 days of ECMO and survival. Higher tidal volume and lower driving pressures over 
the duration of ECMO (likely reflecting gradual improvement in static compliance) were 
associated with better outcomes.
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